top of page
Medizin
AI-assisted breast-cancer screening may reduce unnecessary testing
Using artificial intelligence (AI) to supplement radiologists’ evaluations of mammograms may improve breast-cancer screening by reducing...
Corax Consultants LLC
11. Apr. 20241 Min. Lesezeit
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapse
FOSTER CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) — Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage...
Corax Consultants LLC
10. Apr. 20241 Min. Lesezeit
FDA Roundup: April 9, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: U.S. Food and Drug...
Corax Consultants LLC
9. Apr. 20241 Min. Lesezeit
bottom of page
